PERSPECTA

News from every angle

Back to headlines

Massive Wegovy Sales Could Lead to Novo Nordisk Upgrade

Strong sales of the weight-loss drug Wegovy are anticipated to potentially trigger an upward revision of financial forecasts for pharmaceutical giant Novo Nordisk.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.